VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Ventyx Biosciences, Inc. (VTYX) Total Return Calculator with Dividends Reinvested

Ventyx Biosciences, Inc.

Popular:

The total return for Ventyx Biosciences, Inc. (VTYX) stock is +1057.02% over the past 12 months. So far it's up 66.67% this year. The 5-year total return is -33.40%, meaning $10,000 invested in VTYX stock 5 years ago would be worth $6,660 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in VTYX 1 year ago, it would be worth $115,702 today — you'd have gained $105,702.

With Dividends Reinvested$115,702+1057.02%

Price Only (No DRIP)$115,702+1057.02%

Period2025-05-07 → 2026-03-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in VTYX

1Y$115,702+$105,702 (+1057.0%)1057.0% CAGR

3Y$3,639-$6,361 (-63.6%)-28.6% CAGR

5Y$6,660-$3,340 (-33.4%)-7.8% CAGR

10Y$6,660-$3,340 (-33.4%)-4.0% CAGR

15Y$6,660-$3,340 (-33.4%)-2.7% CAGR

20Y$6,660-$3,340 (-33.4%)-2.0% CAGR

30Y$6,660-$3,340 (-33.4%)-1.3% CAGR

Ventyx Biosciences, Inc. did not pay dividends during this period. Total return = price return.

Loading VTYX total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+66.67%	—	+66.67%	—	$16,667
1Y	+1057.02%	1057.02%	+1057.02%	—	$115,702
3Y	-63.61%	-28.60%	-63.61%	—	$3,639
5Y	-33.40%	-7.81%	-33.40%	—	$6,660
10Y	-33.40%	-3.98%	-33.40%	—	$6,660
15Y	-33.40%	-2.67%	-33.40%	—	$6,660
20Y	-33.40%	-2.01%	-33.40%	—	$6,660
30Y	-33.40%	-1.35%	-33.40%	—	$6,660

Risk & Highlights

Best Year+321.96%2025

Worst Year-91.63%2023

Max Drawdown-29.66%2025-07-17 → 2025-09-12 · Recovered 2025-10-01

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+66.31%	+66.31%	—	+0.41%	+65.9pp
2025	+321.96%	+321.96%	—	+16.64%	+305.3pp
2024	-12.05%	-12.05%	—	+24.00%	-36.0pp
2023	-91.63%	-91.63%	—	+24.81%	-116.4pp
2022	+64.11%	+64.11%	—	-19.95%	+84.1pp

VTYX outperformed the S&P 500 by 1026.65pp over the past year (+1057.02% vs +30.37%).

Loading summary...

VTYX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
VTYXVentyx Biosciences, Inc.	$999M	—	+66.7%	+1057.0%	—	-63.6%	-33.4%	-33.4%
ARQTArcutis Biotherapeutics, Inc.	$2.6B	-11.2%	-28.8%	+50.8%	—	+44.9%	-39.5%	-5.2%
IMVTImmunovant, Inc.	$5.5B	+10.6%	+5.1%	+96.1%	—	+40.9%	+62.4%	+173.6%
PRAXPraxis Precision Medicines, Inc.	$7.5B	+8.7%	+16.4%	+775.0%	—	+1976.5%	-20.8%	-20.1%
KYMRKymera Therapeutics, Inc.	$6.9B	-0.6%	+16.3%	+190.7%	—	+205.1%	+92.1%	+154.4%
TARSTarsus Pharmaceuticals, Inc.	$2.7B	-7.0%	-20.8%	+35.1%	—	+310.3%	+113.3%	+210.8%
RCUSArcus Biosciences, Inc.	$2.5B	+12.3%	+6.5%	+209.6%	—	+24.9%	-18.6%	+45.9%
ABBVAbbVie Inc.	$358.4B	-1.8%	-10.1%	+11.3%	+3.6pp	+50.4%	+101.3%	+295.5%
LLYEli Lilly and Company	$921.2B	+4.7%	-9.6%	+26.3%	+0.8pp	+129.1%	+411.1%	+1237.7%
PFEPfizer Inc.	$150.6B	-2.3%	+6.9%	+23.7%	+7.5pp	-18.4%	-13.3%	+29.6%
INVAInnoviva, Inc.	$1.9B	-2.1%	+14.7%	+21.7%	—	+95.2%	+94.4%	+94.9%

Compare:VTYX vs ARQT VTYX vs IMVT VTYX vs PRAX VTYX vs ARQT vs IMVT

About VTYX Dividend Returns

Ventyx Biosciences, Inc. (VTYX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of VTYX over the past year?

Ventyx Biosciences, Inc. (VTYX) delivered a return of 1057.02% over the past year. Since VTYX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in VTYX be worth today?

A $10,000 investment in Ventyx Biosciences, Inc. one year ago would be worth $115,702 today, representing a gain of $105,702.

Q3Does VTYX pay dividends?

Ventyx Biosciences, Inc. (VTYX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For VTYX, the total return equals the price-only return.

Q4Did VTYX beat the S&P 500?

Yes, Ventyx Biosciences, Inc. (VTYX) outperformed the S&P 500 by 1026.65 percentage points over the past year. VTYX delivered a total return of 1057.02%, compared to the S&P 500's 30.37%. This 1026.65pp alpha means investors in VTYX earned more than a passive S&P 500 index fund.

Q5What is VTYX's worst drawdown?

Ventyx Biosciences, Inc. (VTYX) experienced a maximum drawdown of -29.66% over the past year, declining from its peak on 2025-07-17 to its trough on 2025-09-12. The stock recovered to its prior peak by 2025-10-01. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is VTYX's long-term total return over 10, 20, or 30 years?

Here are Ventyx Biosciences, Inc. (VTYX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -33.4% (-4.0% CAGR) — $10,000 would have grown to $6,660. Over 20 years: -33.4% total return (-2.0% CAGR) — $10,000 → $6,660. Over 30 years: -33.4% total return (-1.3% CAGR) — $10,000 → $6,660. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was VTYX's best and worst year?

Ventyx Biosciences, Inc.'s best calendar year was 2025 with a total return of 322.0%. Its worst year was 2023 with a total return of -91.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 413.6 percentage points.